Peer Valuation & Performance Analysis
Peer group analysis for Thermo Fisher Scientific Inc. (TMO) compared to its primary competitors (including IQV) reveals distinct metrics. TMO trades at a valuation premium compared to its competitors, with a P/E ratio of 36.9x versus the peer average of 33.1x (representing a 12% premium). This indicates that the market expects superior growth or commands a quality premium for TMO. In terms of growth, TMO's revenue growth of 10.5% is consistent with the peer average of 8.7%. Additionally, it boasts superior profitability with a net margin of 15.0% compared to the peer average of 8.1%, demonstrating strong cost controls and pricing power.